<DOC>
	<DOCNO>NCT00857597</DOCNO>
	<brief_summary>The study objective evaluate relative merit , safety effectiveness Transoral Incisionless Fundoplication ( TIF ) GERD patient currently treat daily Proton Pump Inhibitors ( PPIs ) .</brief_summary>
	<brief_title>Endoscopic Fundoplication Versus Proton Pump Inhibitors GERD Treatment</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Age 1875 year Proven gastroesophageal reflux ( pH &lt; 4 &gt; 4.3 % time PPIs 714 day ) On daily PPIs &gt; 1 year Recurrence GERD symptom ( GERDHRQL score difference &gt; 10 PPIs ) Normal hypotonic LES resting pressure ( 540 mmHg ) Patient willingness cooperate random group assignment , attend 45 office visit comply test protocol Signed informed consent BMI &gt; 35 Hiatal hernia &gt; 2 cm Esophagitis grade D Barrett 's esophagus Esophageal stricture Esophageal ulcer Esophageal motility disorder Gastric motility disorder Prior splenectomy Gastric paralysis Pregnancy ( female ) Immunosuppression ASA &gt; 2 Portal hypertension Coagulation disorder Previous antireflux procedure Any health condition , investigator believe would prevent patient complete study Lack fluency English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>GERD</keyword>
	<keyword>endoscopic</keyword>
	<keyword>fundoplication</keyword>
	<keyword>Proton Pump Inhibitors</keyword>
	<keyword>heartburn</keyword>
	<keyword>anti-reflux surgery</keyword>
</DOC>